Portolan Capital Management’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Portolan Capital Management's AGL Position: Q1 2024 in Review
Portolan Capital Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 15,338 shares — an estimated $4.81M sold.
Portolan Capital Management first reported a position in AGL in Q3 2022 and held it in 2 quarters. The position peaked at $4.81M in Q4 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.
- Portolan Capital Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
- Portolan Capital Management sold 15,338 Agilon Health shares in Q1 2024, an estimated $4.81M.
- Portolan Capital Management first reported a position in Agilon Health in Q3 2022 and held it in 2 quarters.
- Portolan Capital Management's Agilon Health position peaked at $4.81M in Q4 2023.
- 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.
Based on Portolan Capital Management's 13F filing for Q1 2024, filed 15 May 2024.